BRIEF REPORT
James Phelps, MD; James Nguyen, BA; Olivia Pipitone Coskey, MPH
Corresponding Author: James Phelps, MD; Samaritan Mental Health, Samaritan Health Services.
Email: jimp@psycheducation.org
DOI: 10.3122/jabfm.2022.220239R1
Keywords: Antidepressants, Anxiety Disorders, Bipolar Disorder, Depression, Drug Tapering, Mental Health, Primary Health Care, Psychiatry
Ahead of Print: | HTML | | PDF | Final Publication: | HTML | | PDF |
INTRODUCTION: When antidepressants are discontinued, severe withdrawal symptoms are possible. Some patients have few or no problems stopping, while others struggle. That struggle can be minimized or prevented with careful dose tapering. We asked: how often is that done?
METHODS: Using 7 years of medical records, we determined the percentage of patients who received a prescription for the lowest available dose of their antidepressant before it was discontinued, as an indicator of a deliberate taper.
RESULTS: Over that period, 8.9% of patients had this evidence of tapering. The percentage increased from 4.9% in 2014 to a plateau around 10% in the last 4 years.
DISCUSSION: While reports of severe withdrawal are increasingly recognized, and must be addressed, our data suggest that many patients can discontinue their antidepressants without a taper through the lowest dose. However, it is difficult to identify which patients will struggle without a careful taper. Therefore a “one-size-fits-all” taper approach is recommended, balancing the need for withdrawal prevention with the need to avoid unnecessary complexity for the majority of patients. The first decrement is key for all patients: it must go well. Thereafter many patients may accelerate but all should receive a prescription for the lowest available dose of their antidepressant. A patient handout describing a suggested taper is presented in a Supplement.